262 related articles for article (PubMed ID: 8435100)
1. Antiplatelet activity of some prenylflavonoids.
Lin CN; Shieh WL; Ko FN; Teng CM
Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
[TBL] [Abstract][Full Text] [Related]
2. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet actions of some coumarin compounds isolated from plant sources.
Teng CM; Li HL; Wu TS; Huang SC; Huang TF
Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation by some flavonoids.
Tzeng SH; Ko WC; Ko FN; Teng CM
Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
[TBL] [Abstract][Full Text] [Related]
6. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
Ding YA; Chou TC; Chern JW; Yen MH
Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
[TBL] [Abstract][Full Text] [Related]
8. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
9. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
Lin CH; Kuo YH; Lin YL; Teng CM
J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
[TBL] [Abstract][Full Text] [Related]
14. Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets.
Oyekan AO; Ablordeppey SY
Gen Pharmacol; 1993 Sep; 24(5):1285-90. PubMed ID: 8270188
[TBL] [Abstract][Full Text] [Related]
15. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Chou TC; Hsu LY; Yen MH; Ding YA
Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
Ostermann G; Hofmann B; Kertscher HP; Till U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]